Guodong Li

1.0k total citations
49 papers, 741 citations indexed

About

Guodong Li is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Guodong Li has authored 49 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 8 papers in Oncology. Recurrent topics in Guodong Li's work include Lung Cancer Diagnosis and Treatment (14 papers), Lung Cancer Treatments and Mutations (7 papers) and Medical Imaging and Pathology Studies (6 papers). Guodong Li is often cited by papers focused on Lung Cancer Diagnosis and Treatment (14 papers), Lung Cancer Treatments and Mutations (7 papers) and Medical Imaging and Pathology Studies (6 papers). Guodong Li collaborates with scholars based in China, United States and Denmark. Guodong Li's co-authors include Hui Zeng, Kai Chen, Dong Fu, Xiaolong Zhang, Jian Li, Quan Li, Wei Sun, Lichao Xu, Haiquan Chen and Wentao Li and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Biochemical Pharmacology.

In The Last Decade

Guodong Li

46 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guodong Li China 14 376 329 104 103 89 49 741
Hu Liao China 13 415 1.1× 228 0.7× 146 1.4× 206 2.0× 73 0.8× 65 827
Carlotta Becherini Italy 15 293 0.8× 121 0.4× 72 0.7× 238 2.3× 162 1.8× 71 641
Quan Zhu China 17 403 1.1× 140 0.4× 82 0.8× 136 1.3× 146 1.6× 56 654
Masayuki Iwazaki Japan 15 358 1.0× 170 0.5× 156 1.5× 199 1.9× 40 0.4× 92 718
Jean-Paul de Vries Netherlands 15 311 0.8× 278 0.8× 124 1.2× 52 0.5× 51 0.6× 31 719
C. Radulescu France 16 355 0.9× 251 0.8× 138 1.3× 255 2.5× 43 0.5× 42 776
Xiangyang Chu China 15 417 1.1× 212 0.6× 174 1.7× 168 1.6× 76 0.9× 44 718
Gürsah Kats‐Ugurlu Netherlands 15 287 0.8× 288 0.9× 109 1.0× 310 3.0× 181 2.0× 53 765
Takeo Kosaka Japan 15 420 1.1× 322 1.0× 95 0.9× 219 2.1× 35 0.4× 85 769

Countries citing papers authored by Guodong Li

Since Specialization
Citations

This map shows the geographic impact of Guodong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guodong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guodong Li more than expected).

Fields of papers citing papers by Guodong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guodong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guodong Li. The network helps show where Guodong Li may publish in the future.

Co-authorship network of co-authors of Guodong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guodong Li. A scholar is included among the top collaborators of Guodong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guodong Li. Guodong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Hualong, Dong Li, Guodong Li, et al.. (2024). Incidence and risk factors for pulmonary hemorrhage after percutaneous CT-guided pulmonary nodule biopsy: an observational study. Scientific Reports. 14(1). 7348–7348. 6 indexed citations
2.
Zhou, Xiaowen, Li Yang, Beibei Li, et al.. (2024). Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy. Science China Life Sciences. 67(5). 996–1009. 20 indexed citations
3.
4.
Li, Guodong, et al.. (2023). Acute exacerbation of idiopathic pulmonary fibrosis treated using the Feibi recipe: Two case reports. World Journal of Clinical Cases. 11(24). 5742–5748.
5.
Chen, Xiaohong, Min Wei, Guodong Li, et al.. (2023). YuPingFeng (YPF) upregulates caveolin-1 (CAV1) to alleviate pulmonary fibrosis through the TGF-β1/Smad2 pathway. Journal of Ethnopharmacology. 319(Pt 3). 117357–117357. 6 indexed citations
6.
Yang, Dong, Tianyang Xu, Lin Fan, Kaiyuan Liu, & Guodong Li. (2021). Correction to: microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis. Journal of Experimental & Clinical Cancer Research. 40(1). 17–17. 13 indexed citations
7.
Liu, Kaiyuan, Yang Dong, Pengfei Zan, et al.. (2020). Preoperative low scores of Life Satisfaction Rating predicts poor outcomes after total knee arthroplasty: a prospective observational study. Journal of Orthopaedic Surgery and Research. 15(1). 145–145. 6 indexed citations
8.
Chen, Chao, Yaohui Wang, Xiaofei Sun, et al.. (2020). Cardiac motion non-influential in percutaneous computed tomography-guided biopsies of small (≤ 20 mm) lung nodules near pericardium. Japanese Journal of Radiology. 38(9). 890–898. 1 indexed citations
9.
Li, Guodong, Xin Zhao, Jianxing Xiang, et al.. (2020). High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy. Annals of Translational Medicine. 8(11). 685–685. 6 indexed citations
10.
Wu, Jieheng, Donghui Han, Shengjia Shi, et al.. (2019). A Novel Fully Human Antibody targeting Extracellular Domain of PSMA Inhibits Tumor Growth in Prostate Cancer. Molecular Cancer Therapeutics. 18(7). 1289–1301. 10 indexed citations
11.
Chu, Li, Jianjiao Ni, Xi Yang, et al.. (2019). Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities. Journal of Cancer. 10(26). 6660–6665. 3 indexed citations
12.
Fan, Lin, et al.. (2017). Morphologic features of the distal femur and tibia plateau in Southeastern Chinese population. Medicine. 96(46). e8524–e8524. 25 indexed citations
13.
Zhao, Yue, Guodong Li, Difan Zheng, et al.. (2016). The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 153(3). 702–709.e1. 30 indexed citations
14.
Lu, Xueguan, et al.. (2015). A prospective clinical trial of radiofrequency ablation for pulmonary metastases. Molecular and Clinical Oncology. 3(3). 559–562. 6 indexed citations
15.
Sun, Mengxiong, Shuo Hu, Bo Gao, et al.. (2013). Benzochloroporphyrin Derivative Induced Cytotoxicity and Inhibition of Tumor Recurrence During Photodynamic Therapy for Osteosarcoma. Asian Pacific Journal of Cancer Prevention. 14(5). 3351–3355. 8 indexed citations
16.
Li, Guodong, et al.. (2013). Dilation-Assisted Stone Extraction: An Alternative Method for Removal of Common Bile Duct Stones. Digestive Diseases and Sciences. 59(4). 857–864. 21 indexed citations
17.
18.
Li, Wentao, Xinhong He, Guodong Li, et al.. (2012). Combination of CT-guided hookwire localization and video-assisted thoracoscopic surgery for pulmonary nodular lesions: Analysis of 103 patients. Oncology Letters. 4(4). 824–828. 27 indexed citations
19.
Gao, Jing, Xueying Ding, Lei Lü, et al.. (2008). Dry powder inhalations containing thymopentin and its immunomodulating effects in Wistar rats. European Journal of Pharmaceutical Sciences. 36(4-5). 572–579. 11 indexed citations
20.
Huo, Jianxin, Stewart A. Metz, & Guodong Li. (2003). Role of tissue transglutaminase in GTP depletion-induced apoptosis of insulin-secreting (HIT-T15) cells. Biochemical Pharmacology. 66(2). 213–223. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hu Liao Breakdown of academic impact, for papers by Carlotta Becherini Breakdown of academic impact, for papers by Quan Zhu Breakdown of academic impact, for papers by Masayuki Iwazaki Breakdown of academic impact, for papers by Jean-Paul de Vries Breakdown of academic impact, for papers by C. Radulescu Breakdown of academic impact, for papers by Xiangyang Chu Breakdown of academic impact, for papers by Gürsah Kats‐Ugurlu Breakdown of academic impact, for papers by Takeo Kosaka
Rankless by CCL
2026